바로가기메뉴

본문 바로가기 주메뉴 바로가기

Tuberculosis & Respiratory Diseases

Article Contents

Prev Next
e-Submission

Vol.78 No.4
Citation Share

Nontuberculous Mycobacterial Lung Disease Caused by Mycobacterium simiae : The First Reported Case in South Korea Suk

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2015, v.78 no.4, pp.432-435










& (2015). Nontuberculous Mycobacterial Lung Disease Caused by Mycobacterium simiae : The First Reported Case in South Korea Suk. Tuberculosis & Respiratory Diseases, 78(4), 432-435.
  • Downloaded
  • Viewed
PDF Download

Abstract

This is a report of the first South Korean case of a lung disease caused by Mycobacterium simiae . The patient was a previously healthy 52-year-old female. All serial isolates were identified as M. simiae by multi-locus sequencing analysis, based on hsp65 , rpoB , 16S-23S rRNA internal transcribed spacer, and 16S rRNA fragments. A chest radiography revealed deterioration, and the follow-up sputum cultures were persistently positive, despite combination antibiotic treatment, including azithromycin, ethambutol, and rifampin. To the best of our knowledge, this is the first confirmed case of a lung disease caused by M. simiae in South Korea.

keywords
Bronchiectasis, Mycobacterium, Nontuberculous Mycobacteria

Reference

1.

1. Griffith DE., Aksamit T., Brown-Elliott BA., Catanzaro A., Daley C., Gordin F. (2007), An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med, 175,367-416.

2.

2. Maoz C., Shitrit D., Samra Z., Peled N., Kaufman L., Kramer MR. (2008), Pulmonary Mycobacterium simiae infection: comparison with pulmonary tuberculosis. Eur J Clin Microbiol Infect Dis, 27,945-50.

3.

3. Velayati AA., Farnia P., Mozafari M., Malekshahian D., Seif S., Rahideh S. (2014), Molecular epidemiology of nontuberculous mycobacteria isolates from clinical and environmental sources of a metropolitan city. PLoS One, 9,e114428.

4.

4. van Ingen J., Boeree MJ., Dekhuijzen PN., van Soolingen D. (2008), Clinical relevance of Mycobacterium simiae in pulmonary samples. Eur Respir J, 31,106-9.

5.

5. Wang HY., Bang H., Kim S., Koh WJ., Lee H. (2014), Identification of Mycobacterium species in direct respiratory specimens using reverse blot hybridisation assay. Int J Tuberc Lung Dis, 18,1114-20.

6.

6. Ben Salah I., Adekambi T., Raoult D., Drancourt M. (2008), rpoB sequence- based identification of Mycobacterium avium complex species. Microbiology, 154,3715-23.

7.

7. Frothingham R., Wilson KH. (1993), Sequence-based differentiation of strains in the Mycobacterium avium complex. J Bacteriol, 175,2818-25.

8.

8. Turenne CY., Tschetter L., Wolfe J., Kabani A. (2001), Necessity of quality- controlled 16S rRNA gene sequence databases: identifying nontuberculous Mycobacterium species. J Clin Microbiol, 39,3637-48.

9.

9. Adekambi T., Colson P., Drancourt M. (2003), rpoB-based identification of nonpigmented and late-pigmenting rapidly growing mycobacteria. J Clin Microbiol, 41,5699-708.

10.

10. Clinical Laboratory Standards Institute. (2011), Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes; approved standard. 2nd ed. CLSI document No. M24-A2. Wayne: Clinical Laboratory Standards Institute.

11.

11. Meier A., Heifets L., Wallace RJ Jr., Zhang Y., Brown BA., Sander P. (1996), Molecular mechanisms of clarithromycin resistance in Mycobacterium avium : observation of multiple 23S rDNA mutations in a clonal population. J Infect Dis, 174,354- 60.

12.

12. El Sahly HM., Septimus E., Soini H., Septimus J., Wallace RJ., Pan X. (2002), Mycobacterium simiae pseudo-outbreak resulting from a contaminated hospital water supply in Houston, Texas. Clin Infect Dis, 35,802-7.

13.

13. Baghaei P., Tabarsi P., Farnia P., Marjani M., Sheikholeslami FM., Chitsaz M. (2012), Pulmonary disease caused by Mycobacterium simiae in Iran’s national referral center for tuberculosis. J Infect Dev Ctries, 6,23-8.

14.

14. van Ingen J., Totten SE., Heifets LB., Boeree MJ., Daley CL. (2012), Drug susceptibility testing and pharmacokinetics question current treatment regimens in Mycobacterium simiae complex disease. Int J Antimicrob Agents, 39,173-6.

15.

15. van Ingen J., van der Laan T., Dekhuijzen R., Boeree M., van Soolingen D. (2010), In vitro drug susceptibility of 2275 clinical nontuberculous Mycobacterium isolates of 49 species in The Netherlands. Int J Antimicrob Agents, 35,169-73.

Tuberculosis & Respiratory Diseases

e-Submission OA Policy